U
Juva Life Inc. JUVAF
$0.00 $0.000.00% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

Juva Life Inc. (OTC: JUVAF) is a cannabis-focused life sciences and consumer products company that has operated primarily in the regulated cannabis industry in the United States, with a concentration in California. The company has historically combined cannabis cultivation, manufacturing, distribution, and retail activities with research initiatives focused on plant-based compounds and therapeutic applications. Public disclosures indicate that the company pursued a vertically integrated operating model intended to connect cultivation and product development with branded consumer offerings and scientific research.

The company’s revenue drivers have historically included cannabis cultivation and distribution activities, branded cannabis products, and retail-related operations. Juva Life also promoted research initiatives involving cannabinoids and other compounds derived from plants, seeking to differentiate itself through intellectual property development and data-driven product research. Based on available public filings and market disclosures, the company evolved from a cannabis operating platform into a broader life sciences-focused strategy, though public information regarding the scale and commercial success of these initiatives remains limited. Certain operational details and current business activity levels are difficult to independently verify through recent public disclosures, and some data is inconclusive based on available public sources.

Business Operations

Juva Life’s historical operating activities included cannabis cultivation, extraction, manufacturing, distribution, and retail support functions primarily within California’s regulated cannabis market. The company previously referenced operations tied to cultivation assets, product formulation capabilities, and consumer packaged cannabis products. Public disclosures also referenced efforts related to research and development involving cannabinoids and plant-based compounds. Revenue generation was tied largely to cannabis-related commercial operations and associated product sales.

The company’s operations appear to have been concentrated domestically within the United States rather than through a broad international operating network. Publicly available filings and investor materials have referenced subsidiaries and affiliated operating entities connected to cultivation and distribution infrastructure, though the structure and operational status of certain subsidiaries have changed over time. Information regarding major active joint ventures or material long-term strategic partnerships is limited in publicly available records, and some operational details cannot be conclusively verified from recent disclosures.

Strategic Position & Investments

Juva Life positioned itself around the convergence of cannabis commercialization and plant-based life sciences research. Its strategic direction historically emphasized vertical integration within cannabis markets while also pursuing intellectual property opportunities linked to cannabinoid science and therapeutic applications. The company publicly discussed initiatives involving research partnerships and the development of proprietary formulations intended to support future product differentiation.

The company also pursued acquisitions and investments connected to cannabis infrastructure and operating capabilities. Public filings referenced efforts to expand cultivation and distribution capacity as part of broader growth initiatives in California. In addition, Juva Life highlighted interest in emerging sectors tied to medicinal cannabis, wellness products, and biotechnology-oriented cannabis applications. However, publicly available information regarding the long-term outcomes of these investments, the current scale of operations, and commercialization progress remains limited, and some data is inconclusive based on available public sources.

Geographic Footprint

Juva Life’s primary operational footprint has historically been within California, which served as the company’s principal commercial market and operational base in the United States. The company has been headquartered in the United States and focused on participating in state-regulated cannabis markets rather than establishing a broad multinational cannabis network. Its activities were largely concentrated in cultivation, manufacturing, distribution, and related life sciences initiatives connected to the California cannabis ecosystem.

While the company has been publicly traded and accessible to investors through U.S. over-the-counter markets, there is limited evidence in public filings of significant direct operating infrastructure across Europe, Asia, Latin America, or other major international regions. Public disclosures suggest that any international influence was more closely associated with investor reach and intellectual property ambitions than with extensive overseas operations.

Leadership & Governance

Juva Life’s leadership structure has evolved over time as the company adjusted its operational and strategic priorities. Public filings and corporate disclosures indicate that the company was led by executives with backgrounds spanning cannabis operations, finance, and life sciences development. The company’s governance approach emphasized combining regulated cannabis market expertise with scientific research initiatives focused on cannabinoid applications and plant-based therapeutics.

Key executives identified in public disclosures have included:

  • Doug Chloupek – Chief Executive Officer
  • Daniele Bilotta – Former Chief Executive Officer
  • Bryan Oberg – Chief Financial Officer

Based on available public records, leadership messaging consistently focused on building a vertically integrated cannabis and life sciences platform centered on research, product innovation, and participation in regulated cannabis markets. Some executive appointments and governance details may have changed over time, and certain current leadership information is inconclusive based on available public sources.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $225.16
B
AAPL NASDAQ $305.93
B
AVGO NASDAQ $392.99
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $115.27
Top Financial Stocks
See All »
B
B
JPM NYSE $362.84
B
V NYSE $364.15
Top Energy Stocks
See All »
B
CVX NYSE $200.00
B
ENB NYSE $50.91
Top Health Care Stocks
See All »
B
LLY NYSE $1,180.16
B
JNJ NYSE $260.35
B
ABBV NYSE $249.46
Top Real Estate Stocks
See All »
B
PLD NYSE $141.03
B
EQIX NASDAQ $1,102.10